Central
Bringing Excellence in Open Access
Annals of Medicinal Chemistry and Research
Cite this article: Santiago-Ruiz S, Polverini E, Manjarrez J, Espinoza KA, Reynoso E, et al. (2016) Virtual Screening of Putative Anticonvulsant Hydantoin
Derived Drugs and Biological Evaluation. Ann Med Chem Res 2(1): 1016.
*Corresponding author
Ig na c io A. Rive ro , C e ntro d e G ra d ua d o s e
Inve stig a c ió n, Instituto Te c no ló g ic o d e Tijua na , P.O . Bo x
1166, 22000, Tijuana, B.C. Méxic o, Tel: 52-664-6233772;
Submitte d: 16 August 2016
Accepted: 05 O c to b e r 2016
Publishe d: 07 O c to b e r 2016
ISSN: 2378-9336
Copyright
© 2016 Rive ro e t a l.
OPEN ACCESS
Ke ywo rds
• Antic o nvulsa nt
• Hyd a nto in
• Pip e rid ine shyd a nto ins
• Ep ile p sy
Research Article
Virtual Screening of Putative
Anticonvulsant Hydantoin
Derived Drugs and Biological
Evaluation
Sandy Santiago-Ruiz
1
, Eugenia Polverini
2
, Joaquin Manjarrez
3
,
Karla A. Espinoza
1
, Edgar Reynoso
1
, and Ignacio A. Rivero
1
*
1
Centro de Graduados e Investigación, Instituto Tecnológico de Tijuana, México
2
Department of Physics and Earth Sciences, University of Parma, Italy
3
Departmento de Formación Reticular del Instituto de Neurología y Neurocirugía,
Nacional de Neurología y Neurocirugía, México
Abstract
It has been found that derivatives of benzyl N-piperidin-4-one have similar effect
than phenytoin drug as an anticonvulsant for the treatment of epilepsy according to
docking simulation studies. This is due to the similar binding mode in these chemicals. In
this study, a series of six N-piperidinespirohydantoins derivatives were prepared by
Bucherer-Bergs reaction, from corresponding N-piperidin-4-ones derivatives benzyl
and phenethyl groups, substituted in the aromatic ring with metoxy and nitro groups.
The hydantoins were evaluated for anticonvulsant activity with maximal electroshock
(MES) induced method in vivo in male Wistar rats in the treatment of epilepsy.
ABBREVIATIONS
MES: Maximal Electro Shock; AEDs: Anti Epileptic Drugs;
CASH: Cycloalkanespirohydantoins; ADT: Autodock Tools; PSH:
Piperidinespirohydantoins; TLC: Thin-Layer Chromatography;
IR: Infrared Spectra; TMS: Tetramethylene Silane; MS: Mass
Spectra; ESI-MS: Electrospray Ionization Mass Spectra; LC/MSD:
Liquid Chromatography/ Mass Spectra Detector
INTRODUCTION
The search for new chemical compounds that have biological
activity, efficiency, effectiveness, reproducibility, stability, and
security, has become paramount to the constant improvements
on current medication. This is important because of a trend in
patients of developing resistance to outdated and sometimes
even current medication creating a constant need for more
innovative pharmaceutical products.
Neurodegenerative diseases have been a huge challenge
for the development of new drugs, since many of them are not
attractive from a commercial point of view. This is the case with
epilepsy, which is one of many diseases that require lifelong
treatment for the patient to remain in a controlled manner and
to be allowed to do all their independent normal activities [1].
Epilepsy is the most common neurological disorder
throughout the world. It is characterized by current unpredictable
epileptic seizures, muscle spasms, physical injury, damage to
the brain, and unconsciousness, to name a few symptoms that
manifest within this disease. As thus, there exists a need for the
development of new anti seizure medication with improved
efficacy and tolerability, as several of the currently available
antiepileptic drugs (AEDs) have been associated with undesirable
side effects [2-4].
There are several drugs that are able to control this disease;
one of the most used is the phenytoin, which contains a hydantoin
ring. Hydantoin (imidazolidine-2,4-dione) moiety constitutes an
attractive and multifaceted pharmacological scaffold present in
several drugs [7]. This small and rigid heterocyclic backbone, has
potential to act on various pharmacological targets.
Hydantoin-1,3-imidazolidinedione derivatives [5,6] Figure
(1) exhibit diverse and interesting pharmacological properties
[7,8]. Several such derivatives (phenytoin, mephenythoin,
norantoin, methetoin, ethotoin, osphenytoin) are renowned
anticonvulsive drugs [9,10] (Table 1).
The anticonvulsant activity of hydantoins has been
known since 1938 when Merrit and Putman discovered that
5,5-diphenylhydantoin (phenytoin) Figure (2) showed anti-
epileptic acivity [11]. Phenytoin acts on brain by reducing
electrical conductance among neurons by stabilizing the inactive
state of voltage gated sodium channel [12-14] (Table 2).